Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-133"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101124.15.3-133"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, ladies and gentlemen, the legislative proposal voted on today, which I supported, outlines the importance of pharmaceutical industries in their delicate role as sources of non-promotional information on their products.
Making patients better informed must give the pharmaceutical industry a sense of responsibility, and it must carry out this task clearly and rigorously, contributing to avoiding the excessive consumption of medicinal products caused by commercial motives. Indeed, this vote emphasises the importance of how information on medicinal products must also be available on the Internet or in hard copy, following specific rules which are the same in all Member States.
However, this does not relieve healthcare professionals of their fundamental role as the primary and irreplaceable source of information for citizens on health and treatment. The agency-style relationship between doctor and patient remains unique and irreplaceable, and verbal communication is affirmed as the basis of any medical treatment. Furthermore, it allows patients to be better informed about the medicinal products they are taking, and it involves them in the treatments they have to undergo, making them active participants in their own recovery."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples